Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-09-05 | Albert D. Bolles, Ph.D, has served as a director since May 2014. Dr. Bolles is currently the Executive Vice President and Chief Technical and Operations Officer of ConAgra. ... The Nominating and Corporate Governance Committee currently consists of Mr. Frank (Chairman), Mr. Tobin, Ms. Pankopf and Dr. Bolles... Dr. Bolles became a member of our Board of Directors late in fiscal year 2014 and did not receive any fees during that fiscal year. |
| 2015-08-24 | Albert D. Bolles, Ph.D, has served as a director since May 2014. Dr. Bolles served as the Executive Vice President and Chief Technical and Operations Officer of ConAgra until his retirement in August 2015. ... The Compensation Committee will consist of Dr. Bolles ... The Nominating and Corporate Governance Committee currently consists of ... Dr. Bolles ... Compensation of Directors table shows Albert D. Bolles, Ph.D. total compensation $145,000. |
| 2018-08-23 | Albert D. Bolles, Ph.D., has served as a director since May 2014. ... The Compensation Committee currently consists of Dr. Sohn (Chairperson), Ms Carosella, Mr. Frank and Dr. Bolles. ... The Nominating and Corporate Governance Committee currently consists of Mr. Frank (Chairperson), Mr. Tobin, Ms. Pankopf and Dr. Bolles. ... The Food Innovation Committee currently consists of Dr. Bolles (Chairperson) and Ms. Carosella. ... The following table sets forth compensation information for the fiscal year ended May 27, 2018, for each member of our Board of Directors who was not an executive officer during fiscal year 2018. ... Albert D. Bolles, Ph.D. $77,500 fee earned or paid in cash, $60,000 stock awards, total $137,500. |
| 2019-08-21 | Dr. Albert Bolles is President and CEO of Landec Corporation and has served as a member of the Board of Directors since May 2014. Prior to becoming the Company’s President and CEO on May 23, 2019, Dr. Bolles was the Chairman of the Food Innovation Committee and a member of the Compensation Committee and Nominating and Corporate Governance Committee. ... In addition, Dr. Bolles received $60,000 in RSUs and $77,500 in cash compensation for his services as a non-employee director in fiscal year 2019, which are included in “Stock Awards” and “All Other Compensation”, respectively. |
| 2020-08-31 | Albert D. Bolles, Ph.D. is President and Chief Executive Officer (“CEO”) of the Company and has served as a member of the Board of Directors since May 2014. Dr. Bolles also currently serves on the Board of Directors of SunOpta, Inc (NASDAQ:STKL), where he is a member of its Corporate Governance Committee, and serves as a director of Arcadia Biosciences, Inc. (NASDAQ:RKDA), where he is a member of its Nominating and Corporate Governance Committee. Prior to becoming the Company’s President and CEO on May 23, 2019, Dr. Bolles was Chairman of the Company's ad hoc Food Innovation Committee and a member of the Company's Compensation and Nominating and Corporate Governance Committees. |
Data sourced from SEC filings. Last updated: 2026-02-08